Stock Performance and Market Context
The stock has been on a declining trajectory for the past two consecutive days, registering a cumulative loss of 3.69% during this period. Today’s fall of 1.79% further accentuates this trend, with the stock underperforming its sector by 1.54%. Notably, Albert David Ltd is trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, signalling sustained bearish momentum.
In comparison, the Sensex opened lower at 83,358.54, down 269.15 points (-0.32%), and is currently trading marginally down by 0.06% at 83,576.01. The benchmark index remains 3.09% shy of its 52-week high of 86,159.02. While the Sensex trades below its 50-day moving average, the 50DMA remains above the 200DMA, indicating a mixed technical picture. Small-cap stocks are leading the market today, with the BSE Small Cap index gaining 0.16%, contrasting with Albert David’s continued weakness.
Financial and Operational Metrics
Albert David Ltd’s financial performance has been under pressure, reflected in its Mojo Score of 17.0 and a Mojo Grade of Strong Sell, upgraded from Sell as of 14 May 2025. The company’s market cap grade stands at 4, indicating relatively modest market capitalisation metrics.
Over the last year, the stock has delivered a negative return of 43.37%, starkly contrasting with the Sensex’s positive 9.25% gain over the same period. The stock’s 52-week high was Rs.1,279.95, underscoring the extent of the decline to the current low of Rs.705.
Quarter after quarter, this Small Cap from the Lifestyle sector delivers without fail! Just added to our Reliable Performers with proven staying power. Stability meets growth here beautifully.
- - Consistent quarterly delivery
- - Proven staying power
- - Stability with growth
See the Consistent Performer →
Underlying Causes of the Decline
The company’s long-term growth trajectory has been notably weak, with operating profit shrinking at an annualised rate of -244.12% over the past five years. This steep contraction in profitability has weighed heavily on investor sentiment and stock performance.
Albert David Ltd has reported negative results for four consecutive quarters, with Profit Before Tax (PBT) excluding other income at Rs. -0.44 crore, a decline of 109.80%. Net profit after tax (PAT) for the quarter stood at Rs. -3.30 crore, down 118.3%. Operating cash flow for the year is also at a low of Rs. -28.44 crore, reflecting cash generation challenges.
The company’s earnings before interest, taxes, depreciation and amortisation (EBITDA) remain negative, contributing to the perception of elevated risk. The stock is trading at valuations that are considered risky relative to its historical averages, further compounding concerns.
Comparative Performance and Risk Assessment
Albert David Ltd’s performance has been below par not only in the near term but also over longer horizons. The stock has underperformed the BSE500 index over the last three years, one year, and three months, highlighting persistent challenges in regaining investor confidence.
Despite these difficulties, the company maintains a low average debt-to-equity ratio of zero, indicating minimal leverage. Promoters remain the majority shareholders, which may provide some stability in ownership structure.
Holding Albert David Ltd from Pharmaceuticals & Biotechnology? See if there's a smarter choice! SwitchER compares it with peers and suggests superior options across market caps and sectors!
- - Peer comparison ready
- - Superior options identified
- - Cross market-cap analysis
Summary of Key Metrics
To summarise, Albert David Ltd’s stock has reached a fresh 52-week low of Rs.705, reflecting ongoing declines amid weak financial results and subdued market sentiment. The stock’s underperformance relative to the Sensex and its sector, combined with negative profitability trends and cash flow pressures, have contributed to its current valuation challenges.
While the company’s low debt levels and promoter majority ownership provide some structural stability, the prevailing financial indicators and market performance metrics underscore the difficulties faced by Albert David Ltd in recent periods.
Market and Sector Overview
The Pharmaceuticals & Biotechnology sector continues to experience mixed performance, with some small-cap stocks leading gains in the broader market. However, Albert David Ltd’s recent price action and financial disclosures place it at the lower end of sector performance rankings.
Investors and market participants will continue to monitor the company’s quarterly results and broader sector developments to assess any shifts in momentum or valuation trends.
Unlock special upgrade rates for a limited period. Start Saving Now →
